{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:52:03Z","timestamp":1792684323979,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.tox.2021.153056","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:49:43Z","timestamp":1638294583000},"page":"153056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The role of mouse and human peroxisome proliferator-activated receptor-\u03b1 in modulating the hepatic effects of perfluorooctane sulfonate in mice"],"prefix":"10.1016","volume":"465","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3519-3899","authenticated-orcid":false,"given":"Shengzhong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Billy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7990-2140","authenticated-orcid":false,"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.153056_bib0005","doi-asserted-by":"crossref","first-page":"39088","DOI":"10.1074\/jbc.M107073200","article-title":"Peroxisome proliferator-activated receptor-\u03b1 regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines","volume":"276","author":"Akiyama","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2021.153056_bib0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1020884312053","article-title":"Food intake, water intake, and drinking spout side preference of 28 mouse strains","volume":"32","author":"Bachmanov","year":"2002","journal-title":"Behav. Genet."},{"key":"10.1016\/j.tox.2021.153056_bib0015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/toxsci\/kfr142","article-title":"Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice","volume":"123","author":"Bijland","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfp093","article-title":"Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures","volume":"111","author":"Bjork","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tox.2011.06.012","article-title":"Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes","volume":"288","author":"Bjork","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.153056_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.01.003","article-title":"Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats","volume":"293","author":"Butenhoff","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.153056_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.reprotox.2009.01.005","article-title":"Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression","volume":"27","author":"Chang","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0045","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/0008-5472.CAN-04-0322","article-title":"Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor-\u03b1","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2021.153056_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","article-title":"The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions","volume":"92","author":"Corton","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tox.2016.12.007","article-title":"Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis","volume":"378","author":"Das","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.153056_bib0065","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2021.153056_bib0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tox.2011.12.014","article-title":"Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPAR\u03b1 and CAR\/PXR","volume":"293","author":"Elcombe","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.153056_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tox.2011.12.015","article-title":"Evaluation of hepatic and thyroid responses in male Sprague Dawley rats for up to eighty-four days following seven days of dietary exposure to potassium perfluorooctanesulfonate","volume":"293","author":"Elcombe","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2021.153056_bib0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab067","article-title":"Differential hepatocarcinogenesis by a potent, high affinity human PPAR\u03b1 agonist in PPARA-humanized mice","volume":"183","author":"Foreman","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfab068","article-title":"Species differences between mouse and human PPAR\u03b1 in modulating the hepatocarcinogenic effects of perinatal exposure to a high affinity human PPAR\u03b1 agonist in mice","volume":"183","author":"Foreman","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbagrm.2016.03.012","article-title":"Regulation of hepatic energy metabolism by the nuclear receptor PXR","volume":"1859","author":"Hakkola","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tox.2021.153056_bib0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12864-015-1969-3","article-title":"The impact of PPAR\u03b1 activation on whole genome gene expression in human precision cut liver slices","volume":"16","author":"Janssen","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.tox.2021.153056_bib0105","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/es1043613","article-title":"Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008","volume":"45","author":"Kato","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tox.2021.153056_bib0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPAR\u03b1 agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2021.153056_bib0120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0125","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the \u03b1 isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tox.2021.153056_bib0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.tox.2021.153056_bib0135","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgi329","article-title":"Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor \u03b1 to Wy-14,643-induced liver tumorigenesis","volume":"27","author":"Morimura","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2021.153056_bib0140","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2021.153056_bib0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.envres.2017.05.013","article-title":"Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015","volume":"157","author":"Olsen","year":"2017","journal-title":"Environ. Res."},{"key":"10.1016\/j.tox.2021.153056_bib0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00109-005-0678-9","article-title":"Peroxisome proliferator-activated receptor-\u03b1 and liver cancer: where do we stand?","volume":"83","author":"Peters","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.tox.2021.153056_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.reprotox.2008.12.011","article-title":"Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species","volume":"27","author":"Ren","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2021.153056_bib0160","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/794739","article-title":"Gene expression profiling in wild-type and PPAR\u03b1-Null mice exposed to perfluorooctane sulfonate reveals PPAR\u03b1-Independent effects","volume":"2010","author":"Rosen","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.tox.2021.153056_bib0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/toxsci\/kfq118","article-title":"Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo","volume":"116","author":"Ross","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/toxsci\/68.1.249","article-title":"Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys","volume":"68","author":"Seacat","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/toxsci\/kfl135","article-title":"Activation of mouse and human peroxisome proliferator-activated receptors (\u03b1, \u03b2\/\u03b4, \u03b3) by perfluorooctanoic acid and perfluorooctane sulfonate","volume":"95","author":"Takacs","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxsci\/kfl014","article-title":"Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-\u03b1, -\u03b2, and -\u03b3, liver X receptor-\u03b2, and retinoid X receptor-\u03b1","volume":"92","author":"Vanden Heuvel","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tox.2021.153056_bib0190","first-page":"21","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-Null mice","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfn166","article-title":"Activation of mouse and human peroxisome proliferator-activated receptor \u03b1 by perfluoroalkyl acids of different functional groups and chain lengths","volume":"106","author":"Wolf","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2021.153056_bib0200","doi-asserted-by":"crossref","first-page":"77004","DOI":"10.1289\/EHP6785","article-title":"Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","author":"Xu","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2021.153056_bib0205","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/toxsci\/kfw120","article-title":"Editor\u2019s highlight: perfluorooctane sulfonate-choline ion pair formation: a potential mechanism modulating hepatic steatosis and oxidative stress in mice","volume":"153","author":"Zhang","year":"2016","journal-title":"Toxicol. Sci."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21003784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21003784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:52:09Z","timestamp":1759535529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21003784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S0300483X21003784"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.153056","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of mouse and human peroxisome proliferator-activated receptor-\u03b1 in modulating the hepatic effects of perfluorooctane sulfonate in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.153056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153056"}}